Skip to content
Allegro Ophthalmics - From Theory to Therapy
  • About
    • Company
    • Management
    • Board of Directors
    • Scientific Advisors
  • Science
  • Pipeline
    • Pipeline
    • Risuteganib
    • ALG-1007
    • Clinical Trials
  • Therapeutic Areas
    • Dry AMD
    • Dry Eye Disease
  • News
    • Press Releases
    • Allegro in the News
    • Events

VIDEO: Allegro at the Ophthalmology Innovation Summit @AAO 2017

Posted on November 9, 2017 | by Allegro Ophthalmics, LLC

Vicken Karageozian, MD, discusses results of a phase-2 trial of an anti-integrin drug for diabetic macular edema.

To view the video, please visit EyeWorld Video Reporter: “Allegro at the Ophthalmology Innovation Summit @AAO 2017”

Posted in News Features
Allegro Ophthalmics - From Theory to Therapy

Setting the pace in ocular care
Read More >

Allegro Ophthalmics LLC
31473 Rancho Viejo Road, Suite 204
San Juan Capistrano, CA 92675, USA

Phone: +1 949.940.8130
Email: info@allegroeye.com

RECENT NEWS

Allegro Ophthalmics Announces New Scientific Data to Be Presented During the 2022 ARVO Annual Meeting
April 27, 2022

AffaMed Therapeutics Enters into a Licensing Agreement with Hanmi Pharmaceutical to Develop and Commercialize Risuteganib (Luminate®) as a First-In-Class Treatment for Intermediate Dry AMD Patients in Greater China
January 3, 2022

  • About
  • Science
  • Pipeline
  • Therapeutic Areas
  • News
  • Careers
  • Contact Us
© 2022 Allegro Ophthalmics, LLC. All rights reserved. | Privacy Policy | Terms of Use